Aldatu Biosciences in Watertown, has developed a rapid test for COVID-19 detection called PANDAA qDx™ SARS-CoV-2 being used in Boston.
RFID:Image ID:2EJH4M4
Image details
Contributor:
Ilene Perlman / Alamy Stock PhotoImage ID:
2EJH4M4File size:
69.1 MB (1.1 MB Compressed download)Releases:
Model - no | Property - noDo I need a release?Dimensions:
6016 x 4016 px | 50.9 x 34 cm | 20.1 x 13.4 inches | 300dpiDate taken:
7 January 2021Location:
Watertown, MAMore information:
Back in March 2020 despite national supply constraints, one of the major Boston hospitals now has the ability to do rapid in-house testing and they are conducting the highest volume of on-site hospital testing in New England, thanks to Boston-based startup, Aldatu Biosciences. Less than three weeks ago, the Aldatu team set to work on developing a test for COVID-19 detection. On Tuesday (March 17th), a Boston hospital with zero prior capacity to test for COVID-19 was using Aldatu’s test to process its first 200 patient samples, with plans to increase to nearly 800 tests per day by week’s end.